These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20842720)

  • 1. Evidence for noncompetitive modulation of substrate-induced serotonin release.
    Rothman RB; Baumann MH; Blough BE; Jacobson AE; Rice KC; Partilla JS
    Synapse; 2010 Nov; 64(11):862-9. PubMed ID: 20842720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
    Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
    Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
    Baumann MH; Ayestas MA; Dersch CM; Rothman RB
    Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
    Giambalvo CT; Price LH
    Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
    Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
    Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
    Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.
    Larsen MB; Sonders MS; Mortensen OV; Larson GA; Zahniser NR; Amara SG
    J Neurosci; 2011 Apr; 31(17):6605-15. PubMed ID: 21525301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
    Fox MA; Stein AR; French HT; Murphy DL
    Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.
    Yubero-Lahoz S; Ayestas MA; Blough BE; Partilla JS; Rothman RB; de la Torre R; Baumann MH
    Eur J Pharmacol; 2012 Jan; 674(2-3):337-44. PubMed ID: 22079770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.
    Hagan CE; Schenk JO; Neumaier JF
    Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
    Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
    J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism.
    Apparsundaram S; Stockdale DJ; Henningsen RA; Milla ME; Martin RS
    J Pharmacol Exp Ther; 2008 Dec; 327(3):982-90. PubMed ID: 18801947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
    Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
    Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
    Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
    Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool.
    Gobbi M; Parazzoli A; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):323-7. PubMed ID: 9774219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
    Kittler K; Lau T; Schloss P
    Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.